EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic enhancement of PARP inhibition via small molecule UNI66-mediated suppression of BRD4-dependent transcription of RAD51 and CtIP

Enkhzul Amarsanaa, Minwoo Wie, Unbeom Shin, Nabeela Bilal, Jungme Hwang, Eun A Lee, Seon Young Lee, Byung-Gyu Kim, Shinseog Kim, Yoonsung Lee, Kyungjae Myung iD

NAR Cancer · 02.04.2025 · 7 (2)

DOI: 10.1093/narcan/zcaf013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAR Cancer, online erschienen am 30.04.2025. Verfasst von Enkhzul Amarsanaa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genomic Integrity, Institute for Basic Science, Ulsan 44919, Republic of Korea. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors, Transcription Factors, Rad51 Recombinase, Cell Cycle Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute for Basic Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted therapy leveraging synthetic lethality in homologous recombination (HR)-defective tumors, particularly in BRCA-mutated tumors through poly(ADP-ribose) polymerase (PARP)-dependent repair inhibition, has shown success. However, the challenge lies in the ability of the tumors to reactivate HR via diverse mechanisms, leading to resistance against PARP-dependent repair inhibition. Addressing this issue, the down-regulation of HR activity has been explored as a potential strategy to overcome PARP inhibitor-resistant tumors. Yet, the intricate modulation of HR gene expression in mammalian cells is still not fully understood. In this study, we used a small molecule, UNI66, identified from high-throughput screening, to investigate regulatory mechanisms of HR. UNI66 was observed to induce synthetic lethality in PARP1-deficient cells and enhanced the sensitivity of multiple cancer cells to PARP inhibitors, suggesting a role in HR down-regulation. Mechanistically, UNI66 was found to interact with and inhibit BRD4 protein binding to the promoters of CtIP and RAD51 genes, resulting in the down-regulation of their transcription. This decrease in CtIP and RAD51 expression was associated with reduced HR activity, thereby increasing the sensitivity of tumors to PARP inhibitors. These findings indicate that BRD4-mediated transcriptional regulation of CtIP and RAD51 influences HR activity, which may have implications for overcoming resistance to PARP inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly(ADP-ribose) Polymerase InhibitorsTranscription FactorsRad51 RecombinaseCell Cycle ProteinsNuclear ProteinsHumansCell Line, TumorDrug SynergismPoly (ADP-Ribose) Polymerase-1Transcription, GeneticHomologous RecombinationDown-RegulationGene Expression Regulation, NeoplasticBromodomain Containing Proteins

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsTranscription FactorsRad51 RecombinaseCell Cycle ProteinsBRD4 protein, humanRAD51 protein, humanPoly (ADP-Ribose) Polymerase-1PARP1 protein, humanNuclear ProteinsBromodomain Containing Proteins

Autor:innen und Institutionen

  • Center for Genomic Integrity, Institute for Basic Science, Ulsan 44919, Republic of Korea.
  • Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.
  • Department of Biomedical Engineering, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.
  • Clinical Research Institute, Kyung Hee University Hospital at Gangdong, School of Medicine, Kyung Hee University, Seoul 05278, Republic of Korea.

ORCID-Profile: Kyungjae Myung

Förderung

  • Institute for Basic Science

Zitieren

APA

Amarsanaa, E., Wie, M., Shin, U., Bilal, N., Hwang, J., Lee, E. A., Lee, S. Y., Kim, B. G., Kim, S., Lee, Y., & Myung, K. (2025). Synergistic enhancement of PARP inhibition via small molecule UNI66-mediated suppression of BRD4-dependent transcription of RAD51 and CtIP. NAR Cancer, 7(2). https://doi.org/10.1093/narcan/zcaf013

Vancouver

Amarsanaa E, Wie M, Shin U, Bilal N, Hwang J, Lee EA, et al. Synergistic enhancement of PARP inhibition via small molecule UNI66-mediated suppression of BRD4-dependent transcription of RAD51 and CtIP. NAR Cancer. 2025;7(2). doi:10.1093/narcan/zcaf013

BibTeX
@article{Amarsanaa2025,
  author = {Amarsanaa, Enkhzul and Wie, Minwoo and Shin, Unbeom and Bilal, Nabeela and Hwang, Jungme and Lee, Eun A and Lee, Seon Young and Kim, Byung-Gyu and Kim, Shinseog and Lee, Yoonsung and Myung, Kyungjae},
  title = {Synergistic enhancement of PARP inhibition via small molecule UNI66-mediated suppression of BRD4-dependent transcription of RAD51 and CtIP},
  journal = {NAR Cancer},
  year = {2025},
  volume = {7},
  number = {2},
  doi = {10.1093/narcan/zcaf013}
}
Kostenlos starten →